These results are in contrast to studies in pancreatic cancer cells, suggesting that the RIPK4 kinase is involved in the regulation of PEBP1 protein levels and consequently affects signaling through the BRAF/MEK/ERK pathway [24]. Here, PEBP1 is linked to pancreatic neoplasm.